The following scenario comes right out of an August 25, 2017 OIG Advisory Opinion. See if you can guess how the OIG ruled. SITUATION A pharmaceutical company manufactures biologics prone to spoilage … [Read more...]
COMPLIANCE
You Make the Call: Is Replacing Spoiled Products for Free an Anti-Kickback Violation?
October 16, 2017
ACQUISITIONS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
September 26, 2017
Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry. M&A The preference of diagnostic companies to work with rather than digest each … [Read more...]
MARKETING
Inside the Lab Industry: The Surge of Do-It-Yourself Test Kits
September 12, 2017
Consumerism, patient empowerment and affordability are key drivers in the modern medical industry. One of the key manifestations of this within the clinical laboratories sector is the rapid growth of … [Read more...]
NEWS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
August 30, 2017
It's been a relatively quiet month on the diagnostic front in terms of both deal volume and impact. Here's a rundown of the deals that did come down. M&A CRO acquisitions were the M&A … [Read more...]
TOP OF THE NEWS
Two App Marketplaces Ramping Up Consumer Genomics Offerings
August 28, 2017
Two personal genome app marketplaces — Sequencing.com (San Francisco, Calif.) and Helix (San Carlos, Calif.)— are now up and running offering consumers a combined total of 55 products for purchase. … [Read more...]
INNOVATION
New Laws: Do-It-Yourself Kits Bring Lab Testing to the Home
August 17, 2017
Health care in the 21st century is moving toward consumerization of medicine, patient empowerment and increased price awareness resulting from higher out-of-pocket medical expenditures. The growth of … [Read more...]
CASE OF THE MONTH
Theranos and Walgreens Bury the Hatchet—For Now
August 14, 2017
It all looked so promising back in 2015. Privately-held Theranos was poised to usher in a new era of diagnostics with its revolutionary fingerprick technology for performing a wide array of tests with … [Read more...]
DEAL TRENDS
Global Markets: Local Joint Ventures Represent New Path into China Market
August 7, 2017
While the strategy of targeting the China market is nothing new, the tactics have evolved. Recognizing the need for a strong local presence, western firms are increasingly teaming with operators on … [Read more...]
ORDERING PHYSICIANS
Ordering Physicians: Oncologists Say Genomic Testing Is Overhyped
August 7, 2017
When it comes to measuring Dx product effectiveness, few things speak louder than the attitudes of ordering physicians. With that in mind, genomic test manufacturers might want to take pause from a … [Read more...]
NEWS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
July 31, 2017
After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all transaction model sectors. Here are the highlights from the past … [Read more...]
